Impacts of genetic polymorphisms and cancer cachexia on naldemedine pharmacokinetics and bowel movements in patients receiving opioid analgesics.

MLA

Nakatsugawa, Emi, et al. “Impacts of Genetic Polymorphisms and Cancer Cachexia on Naldemedine Pharmacokinetics and Bowel Movements in Patients Receiving Opioid Analgesics.” Fundamental & Clinical Pharmacology, vol. 38, no. 3, June 2024, pp. 596–605. EBSCOhost, https://doi.org/10.1111/fcp.12976.

APA

Nakatsugawa, E., Naito, T., Shibata, K., Kitajima, R., & Kawakami, J. (2024). Impacts of genetic polymorphisms and cancer cachexia on naldemedine pharmacokinetics and bowel movements in patients receiving opioid analgesics. Fundamental & Clinical Pharmacology, 38(3), 596–605. https://doi.org/10.1111/fcp.12976

Chicago

Nakatsugawa, Emi, Takafumi Naito, Kaito Shibata, Ryo Kitajima, and Junichi Kawakami. 2024. “Impacts of Genetic Polymorphisms and Cancer Cachexia on Naldemedine Pharmacokinetics and Bowel Movements in Patients Receiving Opioid Analgesics.” Fundamental & Clinical Pharmacology 38 (3): 596–605. doi:10.1111/fcp.12976.